Literature DB >> 3834227

Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood.

A T Nguyen, C Lethias, J Zingraff, A Herbelin, C Naret, B Descamps-Latscha.   

Abstract

The production of reactive oxygen species by phagocytes from uremic patients undergoing hemodialysis was monitored by chemiluminescence (CL) within microamounts of whole blood or isolated polymorphonuclear (PMN) cells, and compared on the basis of the dialysis membrane, cuprophane (CUP) or polyacrilonitrile (PAN). Compared to control subjects, resting and stimulated CL (with latex, zymosan, phorbol myristate acetate (PMA) but not formyl-methionyl-leucyl-phenylalanine (FMLP) were decreased in 10(-2) diluted blood sampled before dialysis. After 15 min of dialysis (ti), resting whole blood (10(-1) and 10(-2) diluted) CL increased sharply in patients dialyzed with the CUP but not the PAN membrane, while it returned to its predialysis level at the end of the session. This sharp resting CL increase found in whole blood at ti was not observed in isolated PMN cells except when tested with ti plasma from CUP dialyzed patients, suggesting that it was mediated via activated plasma compounds. In vitro treatment of normal blood, plasma, and isolated PMN cells with CUP membrane fragments reproduced this in vivo dialysis-induced activation of phagocyte oxidative metabolism strikingly and demonstrated additionally the requirement of complement for its induction. We propose this model as an effective means of evaluating dialysis membrane biocompatibility.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834227     DOI: 10.1038/ki.1985.136

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Complement activation by cellulose: investigation of the effects of time, area, flow rate, shear rate and temperature on C3a generation in vitro, using a parallel plate flow cell.

Authors:  N M Lamba; J D Gaylor; J M Courtney; G D Lowe
Journal:  J Mater Sci Mater Med       Date:  1998-07       Impact factor: 3.896

2.  Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals.

Authors:  C Capeillere-Blandin; T Delaveau; B Descamps-Latscha
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

Review 3.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 4.  Dialysis arthropathy, amyloidosis and beta-2 microglobulin.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

5.  Fall in peak expiratory flow during haemodialysis in patients with chronic renal failure.

Authors:  A Davenport; A J Williams
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

6.  Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients.

Authors:  Davide Soldini; Hugo Zwahlen; Luca Gabutti; Antonio Marzo; Claudio Marone
Journal:  Eur J Clin Pharmacol       Date:  2005-01-19       Impact factor: 2.953

Review 7.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

8.  Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation. Time-course of glutathione peroxidase repletion and lipid peroxidation decrease.

Authors:  M J Richard; V Ducros; M Forêt; J Arnaud; C Coudray; M Fusselier; A Favier
Journal:  Biol Trace Elem Res       Date:  1993 Nov-Dec       Impact factor: 3.738

9.  Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes.

Authors:  A R Rosenkranz; E Templ; O Traindl; H Heinzl; G J Zlabinger
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

10.  Changes in antioxidant status associated with haemodialysis in chronic kidney disease.

Authors:  Adeyemi Ogunleye; Akinwumi A Akinbodewa; Oluseyi A Adejumo; Tosin T Oluwafemi; Damilola A Akinfaderin
Journal:  Ghana Med J       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.